CorMedix (CRMD) Gross Profit (2013 - 2026)
CorMedix (CRMD) posted Gross Profit of $107.3 million for Q4 2025, up 15.28% sequentially from $93.1 million in Q3 2025, and up 257.28% YoY from $30.0 million in Q4 2024.
CorMedix (CRMD) Gross Profit (2013 - 2026) Analysis & Trends
CorMedix has reported Gross Profit for 12 years, with the latest figure at $107.3 million in Q4 2025.
- Quarterly Gross Profit rose 257.28% year-over-year to $107.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $275.7 million (up 584.54% YoY) and the FY2025 annual result came in at $275.7 million, up 584.54% from the prior year.
- Gross Profit grew to $107.3 million in Q4 2025 per CRMD's latest filing, from $93.1 million in the prior quarter.
- Over five years, Gross Profit peaked at $107.3 million in Q4 2025 and troughed at -$818539.0 in Q1 2024.
- A 4-year average of $19.8 million and a median of $28109.0 in 2021 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2021 and 2025: Gross Profit plunged 127.47% in 2021, then surged 12683.29% in 2025.
- Over 4 years, Gross Profit stood at $8390.0 in 2021, then jumped by 249.18% to $29296.0 in 2022, then surged by 102421.64% to $30.0 million in 2024, then jumped by 257.28% to $107.3 million in 2025.
- According to Business Quant data, Gross Profit over the past three periods registered $107.3 million, $93.1 million, and $37.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.13 Mn |
| Jun 30, 2026 | 77.13 Mn |
| Dec 31, 2025 | 107.31 Mn |
| Dec 31, 2025 | 107.31 Mn |
| Sep 30, 2025 | 93.08 Mn |
| Sep 30, 2025 | 93.08 Mn |
| Jun 30, 2025 | 37.87 Mn |
| Jun 30, 2025 | 37.87 Mn |
| Mar 31, 2025 | 37.48 Mn |
| Mar 31, 2025 | 37.48 Mn |
| Dec 31, 2024 | 30.03 Mn |
| Dec 31, 2024 | 30.03 Mn |
| Sep 30, 2024 | 10.77 Mn |
| Sep 30, 2024 | 10.77 Mn |
| Jun 30, 2024 | 296,280.00 |
| Jun 30, 2024 | 296,280.00 |
| Mar 31, 2024 | -818,539.00 |
| Mar 31, 2024 | -818,539.00 |
| Dec 31, 2022 | 29,296.00 |
| Dec 31, 2022 | 29,296.00 |